406 related articles for article (PubMed ID: 19303426)
1. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Schroeder A; Kost J; Barenholz Y
Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
[TBL] [Abstract][Full Text] [Related]
4. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
[TBL] [Abstract][Full Text] [Related]
5. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
[TBL] [Abstract][Full Text] [Related]
6. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
[TBL] [Abstract][Full Text] [Related]
7. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonically activated chemotherapeutic drug delivery in a rat model.
Nelson JL; Roeder BL; Carmen JC; Roloff F; Pitt WG
Cancer Res; 2002 Dec; 62(24):7280-3. PubMed ID: 12499270
[TBL] [Abstract][Full Text] [Related]
10. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
11. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
Frenkel V; Etherington A; Greene M; Quijano J; Xie J; Hunter F; Dromi S; Li KC
Acad Radiol; 2006 Apr; 13(4):469-79. PubMed ID: 16554227
[TBL] [Abstract][Full Text] [Related]
12. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Schroeder A; Avnir Y; Weisman S; Najajreh Y; Gabizon A; Talmon Y; Kost J; Barenholz Y
Langmuir; 2007 Mar; 23(7):4019-25. PubMed ID: 17319706
[TBL] [Abstract][Full Text] [Related]
13. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
14. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
15. Using PEGylated nano-liposomes to target tissue invaded by a foreign body.
Schroeder A; Sigal A; Turjeman K; Barenholz Y
J Drug Target; 2008 Aug; 16(7):591-5. PubMed ID: 18686129
[TBL] [Abstract][Full Text] [Related]
16. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model.
Yuh EL; Shulman SG; Mehta SA; Xie J; Chen L; Frenkel V; Bednarski MD; Li KC
Radiology; 2005 Feb; 234(2):431-7. PubMed ID: 15671000
[TBL] [Abstract][Full Text] [Related]
17. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model.
Son JY; Shin JW; Wang JH; Park HJ; Kim HG; Raghavendran HR; Son CG
Hum Exp Toxicol; 2011 Jul; 30(7):649-55. PubMed ID: 20630914
[TBL] [Abstract][Full Text] [Related]
20. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
